Kaleido Biosciences KLDO Stock
Kaleido Biosciences Price Chart
Kaleido Biosciences KLDO Financial and Trading Overview
| Kaleido Biosciences stock price | 0.0001 USD |
| Previous Close | 1.0E-6 USD |
| Open | 1.0E-6 USD |
| Bid | 0 USD x 1200 |
| Ask | 0 USD x 1800 |
| Day's Range | 1.0E-6 - 1.0E-6 USD |
| 52 Week Range | 1.0E-6 - 0.1 USD |
| Volume | 165 USD |
| Avg. Volume | 5.18K USD |
| Market Cap | 42 USD |
| Beta (5Y Monthly) | 0.534739 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.16 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 22 USD |
KLDO Valuation Measures
| Enterprise Value | -16779958 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.1764705E-6 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.804348E-5 |
| Price/Book (mrq) | 4.0160644E-6 |
| Enterprise Value/Revenue | -15.199 |
| Enterprise Value/EBITDA | 0.197 |
Trading Information
Kaleido Biosciences Stock Price History
| Beta (5Y Monthly) | 0.534739 |
| 52-Week Change | -99.98% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.1 USD |
| 52 Week Low | 1.0E-6 USD |
| 50-Day Moving Average | 0.0001218 USD |
| 200-Day Moving Average | 0.00100945 USD |
KLDO Share Statistics
| Avg. Volume (3 month) | 5.18K USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 42.62M |
| Float | 42.45M |
| Short Ratio | 29.34 |
| % Held by Insiders | 0.73% |
| % Held by Institutions | 0.012% |
| Shares Short | 2.34M |
| Short % of Float | 14.18% |
| Short % of Shares Outstanding | 5.48% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | December 31, 2021 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -7927.71% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -99.92% |
| Return on Equity (ttm) | -580.57% |
Income Statement
| Revenue (ttm) | 1.1M USD |
| Revenue Per Share (ttm) | 0.03 USD |
| Quarterly Revenue Growth (yoy) | 102.49% |
| Gross Profit (ttm) | -66699000 USD |
| EBITDA | -85164000 USD |
| Net Income Avi to Common (ttm) | -90288000 USD |
| Diluted EPS (ttm) | -2.16 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 38.47M USD |
| Total Cash Per Share (mrq) | 0.9 USD |
| Total Debt (mrq) | 21.69M USD |
| Total Debt/Equity (mrq) | 204.53 USD |
| Current Ratio (mrq) | 1.425 |
| Book Value Per Share (mrq) | 0.249 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -77094000 USD |
| Levered Free Cash Flow (ttm) | -46024000 USD |
Profile of Kaleido Biosciences
| Country | United States |
| State | MA |
| City | Lexington |
| Address | 65 Hayden Avenue |
| ZIP | 02421 |
| Phone | 617 674 9000 |
| Website | https://kaleido.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 76 |
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and inflammatory bowel diseases. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.
Q&A For Kaleido Biosciences Stock
What is a current KLDO stock price?
Kaleido Biosciences KLDO stock price today per share is 0.0001 USD.
How to purchase Kaleido Biosciences stock?
You can buy KLDO shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kaleido Biosciences?
The stock symbol or ticker of Kaleido Biosciences is KLDO.
Which industry does the Kaleido Biosciences company belong to?
The Kaleido Biosciences industry is Biotechnology.
How many shares does Kaleido Biosciences have in circulation?
The max supply of Kaleido Biosciences shares is 42.62M.
What is Kaleido Biosciences Price to Earnings Ratio (PE Ratio)?
Kaleido Biosciences PE Ratio is now.
What was Kaleido Biosciences earnings per share over the trailing 12 months (TTM)?
Kaleido Biosciences EPS is -2.16 USD over the trailing 12 months.
Which sector does the Kaleido Biosciences company belong to?
The Kaleido Biosciences sector is Healthcare.